|
AU2019223053A1
|
|
Patient assessment method
|
|
WO2019154472A1
|
|
Efficient cell culture system for hepatitis c virus genotype 6a
|
|
WO2016066171A1
|
|
Optimized hcv full-length infectious cell culture systems and applications thereof
|
|
WO2016008496A1
|
|
Plate for sagittal correction of the spine
|
|
WO2015158353A1
|
|
Development of methods for production of a whole virus vaccine candidate stock and novel adaptive mutations in hepatitis c virus
|
|
WO2015058772A2
|
|
Novel hcv culture systems and direct-acting antiviral sensitivity
|
|
WO2015014369A1
|
|
High-titer hcv full-length genotype 2b infectious cell culture systems and applications thereof
|
|
DK201470274A
|
|
Biodegradable stent for use in the treatment of acute and chronic pancreatitis
|
|
US2015152392A1
|
|
HCV full-length infectious cell culture systems and applications thereof
|
|
AU2013200398A1
|
|
Soluble Urokinase Plasminogen Activator Receptor (suPAR) as Marker for Diseases
|
|
WO2012139591A1
|
|
Monitoring liver fibrosis in a hepatitis c infected patient
|
|
WO2012107046A1
|
|
A breakable vessel for sample storage
|
|
WO2012076020A1
|
|
A method for generating, storing, transporting, eluting and detecting clinical relevant information in plasma using filter paper
|
|
WO2012072083A1
|
|
Safety needle device
|
|
EP2578184A1
|
|
Biodegradable stent for use in the treatment of acute and chronic pancreatitis.
|
|
WO2011137902A1
|
|
Hyperthermia augmented in-vitro immune recognition
|
|
WO2011039639A2
|
|
Jfh-1 based hcv cell culture systems for ns5a of genotypes 1-7
|
|
WO2011038737A1
|
|
Infectious hepatitis c viruses of genotype 3a and 4a and uses thereof
|
|
EP2344647A1
|
|
Hepatitis c virus expressing reporter tagged ns5a protein
|
|
WO2010022727A1
|
|
INFECTIOUS GENOTYPE 1a, 1b, 2a, 2b, 3a, 5a, 6a and 7a HEPATITIS C VIRUS LACKING THE HYPERVARIABLE REGION 1 (HVR1)
|
